High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.6M
$3,559,495
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
DNTH
M
Dianthus Therapeutics, Inc. /DE/
CARR EDWARD
• Officer • CHIEF ACCOUNTING OFFICER
Other
2026-03-12
$893,259x3
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • CHIEF ACCOUNTING OFFICER
Other
|
2026-03-12 | $893,259x3 | M | Form 4 |
|
DNTH
S
Dianthus Therapeutics, Inc. /DE/
CARR EDWARD
• Officer • CHIEF ACCOUNTING OFFICER
10b5-1 SellΔOwn -36.3%
2026-03-12
$3,559,495Largex5
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • CHIEF ACCOUNTING OFFICER
10b5-1 SellΔOwn -36.3%
|
2026-03-12 | $3,559,495Largex5 | S | Form 4 |